Low Dose Naltrexone for Autoimmune Diseases

Low Dose Naltrexone for Autoimmune Diseases Written by Johnette Cruz, Published on November 13, 2025 https://wibc.com/780419/low-dose-naltrexone-for-autoimmune-diseases/ BROWNSBURG, IN – A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine, offering a new approach for people suffering from chronic autoimmune disorders. In an exclusive […]

Empowering Health: Shanika’s Journey with Autoimmune Diseases

  Empowering Health: Shanika’s Journey with Autoimmune Diseases Shanika shares her long journey with autoimmune diseases, beginning with psoriasis in her youth. She highlights the challenges of managing symptoms and the struggle for a proper diagnosis. After years, she is diagnosed with sarcoidosis and finds relief through low dose naltrexone. As an advocate for LDN, […]

LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone

LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone by The FINANCIAL  March 3, 2025 https://finchannel.com/ldn-the-anti-inflammatory-and-longevity-potential-of-low-dose-naltrexone/124870/business-2/2025/03/ Low Dose Naltrexone (LDN) is emerging as a promising tool in longevity science. Originally approved to treat opioid addiction in high doses, researchers have discovered that at lower doses, naltrexone plays a key role in reducing inflammation, modulating […]

Protocol for Vaccine Injury Management

Protocol for Vaccine Injury Management Based on the immune picture revealed by Yale LISTEN study Koolbeens cafe, March 02, 2025 A recent Yale study (preprint) provided a picture of the immune system in post vaccine syndrome (PVS) patients. I have already recorded a video presenting this picture. Sadly, this picture is evidence for an overstimulated […]

AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging

Digital Journal.com AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging PRESS RELEASE Published August 30, 2024 Ann Arbor, MI – AgelessRx, a leading online telehealth platform specializing in longevity science, is proud to announce promising results from their recent study on Low Dose Naltrexone (LDN) for Quality of Life (QoL) […]

Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs

Reza G. Marangaloo et al., German Journal of Veterinary Research, 20th February 2024 https://gmpc-akademie.de/articles/1709702482_2024_4_1_0070_GJVR_Marangaloo.pdf Abstract Naltrexone was first developed in 1963 as an opioid antagonist for therapeutic use in opioid-dependent individuals (alcohol, narcotics, and tobacco) with a 50 mg/day dose approved by the Food and Drug Administration (FDA). In 1985, Dr. Bernard Bihari explained that when […]